Frederick Klauschen, Germany | Digital pathology - a prerequisite for precision medicine #ESPBilbao2018 #digitalPathology #molecularData

Impressions of the AI for Health meeting. Highlights include the presentation of W. Samek (Fraunhofer HHI) on selection of data for AI evaluation, and the presentation of M. Wenzel (Fraunhofer HHI) on behalf of F. Klauschen (Charité), on the use of AI to detect breast cancer.

Read the latest research of our colleagues on explainable #ai in #pathology illustrating our precision approach

Charité - Universitätsmedizin Berlin TU Berlin VomLaborInDiePraxis And if you'd like to learn more about machine learning, join the colloquium of IRI Life Sciences on Sep 26th where Frederick Klauschen will talk about machine learning applications in biomedicine t1p.de/t45o

New research from our colleagues on head and neck tumor metastasis analysis with AI - check it out here (German only for now): aerzteblatt.de/nachrichten/10…

The last European action plan against cancer dates back 30 years. In the meantime: ❗The world has changed. ❗Europe has changed. ❗And the number of cases is on the rise. This is why on #WorldCancerDay, we begin a common path that will lead to Europe's Beating Cancer Action.

Digitales Bildanalysesystem unterstützt Pathologen bei Beurteilung mikroskopischer Präparate: Berlin – Wissenschaftler vom Pathologischen Institut der Charité – Universitätsmedizin Berlin haben gemeinsam mit Forschern… dlvr.it/RVcfnW #KI #Bildanalyse #Pathologie

We are thrilled to announce that we just closed a €5m Seed Round. A special thanks to Charité - Universitätsmedizin Berlin, TU Berlin, @berlinnovation, and Ascenion GmbH for all the help! #DigitalPathology #DigitalHealth #ExplainableAI aignostics.com/aignostics-clo…

We are happy to support #EMPAIA, which was officially kicked off today. EMPAIA is a large Charité-led consortium aimed at creating a neutral, vendor-agnostics platform to deploy AI applications into pathology labs, initially in Germany but hopefully soon also internationally.

Der virtuelle Assistent tagesspiegel.de/wissen/kuenstl…

Another interesting read featuring our founder Frederick Klauschen and our friends over at Vara AI berliner-zeitung.de/zukunft-techno…

We are happy to share this new paper featuring our very own Miriam Haegele, Frederick Klauschen and Klaus-Robert Müller as co-authors, as well as our #ExplainableAI approach. nature.com/articles/s4225…

Thank you @Forbes_DACH for selecting us as one of the top 30 startups in AI this year. We are excited to be part of this landscape! forbes.at/artikel/forbes…

We are thrilled to announce that we raised a €14m Series A led by Wellington Partners - you can read the full press release here: aignostics.com/aignostics-rai…

We are delighted to announce that Aignostics has been awarded a 3 year grant under the “ProFIT” initiative. It was approved by the Investitionsbank Berlin (IBB) and is co-financed by the European Union under the EU Regional Development Fund (ERDF). aignostics.com/news/aignostic…

The #aignostics team is heading to #ASCO2024! Interested in hearing about how we’re transforming precision medicine with our industry-leading foundation model and advanced machine learning algorithms? Let’s connect on June 2-3: lnkd.in/e7eTNxEw #ASCO24 #PrecisionMedicine

🧵I am excited to share that our paper: AI-Based Anomaly Detection for Clinical-Grade Histopathological Diagnostics has now been published in NEJM AI . ai.nejm.org/doi/full/10.10…

Frederick Klauschen on statistical challenges of precision medicine. Primary tumour site still key. #ISCB2016